What's new

[PIO] National Vaccination Advisory Committee recommendations for updated, adapted COVID-19 vaccines

29949.jpg





The Ministry of Health's National Advisory Committee on Vaccination has met today, Thursday 8 September, and evaluated the new recommendations of the European Medicines Agency (EMA), the ECDC, the World Health Organization and pharmaceutical companies regarding updated, adapted COVID-19 vaccines.

The Committee stresses that protection against infection, and particularly against mild disease, decreases approximately six months after the initial vaccination. At the same time, according to Ministry of Health statistics, most admissions of patients with COVID-19 disease occur in unvaccinated individuals. Therefore, the original COVID-19 vaccines continue to provide protection against serious disease, hospitalization and death and will be used for primary vaccinations.

The National Advisory Committee on Immunization of the Department of Health, recommends the use of updated updated vaccines against COVID-19, as:

a) booster/3rd dose in individuals 12 years of age and older, provided that a period of five (5) months has elapsed since receiving the 2nd dose.

2nd booster/4th dose in individuals:

  1. over 30 years of age,
  2. regardless of age who reside or work in nursing homes and closed structures,
  3. health care professionals of any age (presenting a professional license),
  4. with diabetes mellitus,
  5. with severe obesity: BMI ≥40 or ≥35 with metabolic syndrome,
  6. with severe chronic cardiovascular disease,
  7. with severe chronic kidney disease,
  8. with severe chronic liver disease,
  9. with severe chronic neurological disease,
  10. with haemoglobinopathies,
  11. in pregnant women,
  12. in immunocompromised and immunosuppressed patients regardless of age such as:

- in active treatment for solid tumours and haematological malignancies,

- with a history of solid organ transplantation receiving immunosuppressive therapy,

- with a history of primary hematopoietic organ transplantation receiving immunosuppressive therapy,

- with hereditary immunodeficiency,

- with HIV infection/AIDS,

- on immunosuppressive therapy including biological agents,

- with renal failure undergoing dialysis or peritoneal dialysis,

- with regard to cortisone intake,

- with regard to cortisone intake refers to subjects who have received or are receiving a total dose of '10 mg prednisone/day (=8 mg methylprednisolone) for one (1) month in the last six months,

provided that a period of five (5) months has elapsed since receiving the booster/3rd dose.

The recommendations of the National Advisory Committee on Immunization of the Ministry of Health will be endorsed by the Council of Ministers at its next meeting.

(AF)
Contents of this article including associated images are owned by PIO
Views & opinions expressed are those of the author and/or PIO

Source

[/P]
 
Back
Top